Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186004 · ClinicalTrials.gov registry record
Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 21
- Enrollment target
NCT00186004: Completed study, sponsored by Stanford University.
NCT00186004 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186004 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.
Interventions
- DEVICE Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2002-12 |
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186004
The ClinicalTrials.gov registry entry for NCT00186004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.
NCT00186004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186004 about?
NCT00186004 is a clinical study titled "Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes". We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.
What is the current status of trial NCT00186004?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2002-12. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00186004?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT00186004?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.